Search results for "Baseline"

showing 10 items of 299 documents

The WHAAM Application: a Tool to Support the Evidence-Based Practice in the Functional Behaviour Assessment

2018

BackgroundThe most recent computing technologies can promote the application of evidence-based practice (EBP) in the field of applied behaviour analysis (ABA).ObjectiveThe study describes how the use of technology can simplify the application of EBPs in ABA.MethodsThe Web Health Application for ADHD Monitoring (WHAAM) application demonstrates this in the following two case studies. We are monitoring dysfunctional behaviours, collecting behavioural data, performing systematic direct observations, creating both visual baseline and intervention charts and evaluating the planned interventions using the TAU-U statistical index.ResultsSignificant positive changes of children’s problem behaviours …

MaleParents050103 clinical psychologyEvidence-based practiceAdolescentmedicine.medical_treatmenteffect sizeApplied psychologyPsychological interventionHealth InformaticsDysfunctional familylcsh:Computer applications to medicine. Medical informaticsinformation processingeHealth systemHealth Information Managementbehavioural interventionIntervention (counseling)Surveys and QuestionnairesmedicineHumansADHD0501 psychology and cognitive sciences050102 behavioral science & comparative psychologyDuration (project management)Applied behavior analysisBaseline (configuration management)ChildProblem Behaviorbehavioural assessmentInternetCommunication05 social sciencesInformation processingTelemedicineComputer Science ApplicationsAttention Deficit Disorder with HyperactivityEvidence-Based Practicelcsh:R858-859.7behavioural interventionsPsychologySettore M-PSI/05 - Psicologia SocialeMedical Informatics
researchProduct

Changes in 10-12 year old's fruit and vegetable intake in Norway from 2001 to 2008 in relation to gender and socioeconomic status - a comparison of t…

2011

Published version of an article in the journal: International Journal of Behavioral Nutrition and Physical Activity. Also available from the publisher BMC: http://dx.doi.org/10.1186/1479-5868-8-108. Open Access BACKGROUND:Norwegian children and adolescents eat less than half of the recommended 5 portions of fruit and vegetables (FV) per day. Gender and socioeconomic disparities in FV consumption shows that boys and children of lower socioeconomic status (SES) eat less FV than girls and high SES children. We also know that accessibility and preferences has been identified as two important determinants of FV intake. The objectives of this study were to compare FV intake among Norwegian 6th an…

MaleParentsGerontologyAdolescentCross-sectional studyMedicine (miscellaneous)Physical Therapy Sports Therapy and RehabilitationClinical nutritionNorwegianSocial classDiet SurveysFruit and vegetable intakeVDP::Medical disciplines: 700::Health sciences: 800::Nutrition: 811Food Supplysocioeconomic statusSex FactorschildrenVegetablesgenderHumansChildSocioeconomic statuslcsh:RC620-627time trendsNutrition and DieteticsFood frequencyNorwayResearchlcsh:Public aspects of medicinelcsh:RA1-1270Feeding BehaviorBaseline surveySDG 10 - Reduced Inequalitieslanguage.human_languageDietPeer reviewlcsh:Nutritional diseases. Deficiency diseasesCross-Sectional StudiesSocial ClassFruitlanguage/dk/atira/pure/sustainabledevelopmentgoals/reduced_inequalitiesEducational StatusFemaleEnergy IntakePsychologyDemographyInternational Journal of Behavioral Nutrition and Physical Activity
researchProduct

Comparison of myopic progression in Finnish and Singaporean children

2020

Purpose To compare 3-year myopic progression between Finnish and Singaporean children. Methods Myopic progression was compared between 9-year-old (mean age 9.7 ± 0.4 years, n = 92) and 11-year-old (mean age 11.7 ± 0.4 years, n = 144) Finnish (Finnish RCT) children and Singaporean children matched by age and refraction (SCORMMatched, n = 403) and 7- to 8-year-old Singaporean children matched only by refraction (SCORM Young, n = 186). Spherical equivalent (SE) was between −0.50 and −3.00 D. Refraction with cycloplegia was controlled annually for 3 years. Information on parental myopia, mother’s education, time spent on near-work and outdoor time was gathered by parental questionnaire. Results…

MalePediatricsmedicine.medical_specialtyYounger agegenetic structurestaittovirheetlikinäköisyysSpherical equivalentlapset (ikäryhmät)Refraction Ocularlaw.invention03 medical and health sciencesnear work0302 clinical medicineRandomized controlled trialRisk FactorslawSurveys and QuestionnairesSuomiMyopiaHumansMedicineNear workChildFinlandSingaporebusiness.industryVision TestsMean ageCycloplegiaGeneral Medicinemyopia progressionOphthalmologyoutdoorsDisease Progression030221 ophthalmology & optometryFemalemedicine.symptomage of baselinebusinessikä030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic…

2021

Background Recent guidelines suggested a wider use of long-acting injectable antipsychotics (LAI) than previously, but naturalistic data on the consequences of LAI use in terms of discontinuation rates and associated factors are still sparse, making it hard for clinicians to be informed on plausible treatment courses. Objective Our objective was to assess, under real-world clinical circumstances, LAI discontinuation rates over a period of 12 months after a first prescription, reasons for discontinuation, and associated factors. Methods The STAR Network ‘Depot Study’ was a naturalistic, multicentre, observational prospective study that enrolled subjects initiating a LAI without restrictions …

MalePediatricsrespectively)0302 clinical medicineDelayed-Action PreparationBrief Psychiatric Rating ScalePharmacology (medical)he STAR Network ‘Depot Study’ prospectively followed 394 subjects initiating treatment with long-acting injections (LAIs) of antipsychotics under naturalistic conditions for 12 months. LAI discontinuation was frequent in everyday clinical practice in ItalyOriginal Research ArticleProspective StudiesProspective cohort studytreatmentMental DisordersHazard ratiowhereas more than half of participants initiating risperidone LAI and olanzapine LAI discontinued during the 12 months of follow-up (51.4 and 62.5%Psychiatric Status Rating ScaleMiddle Agedside efectsPsychiatry and Mental healthItalyMental DisorderFemalehe STAR Network ‘Depot Study’ prospectively followed 394 subjects initiating treatment with long-acting injections (LAIs) of antipsychotics under naturalistic conditions for 12 months. LAI discontinuation was frequent in everyday clinical practice in Italy occurring in almost 40% of the entire sample; side efects participant refusal to continue LAIs and LAIs no longer being required were the most frequently reported reasons for discontinuation. Paliperidone LAI and aripiprazole LAI were the least discontinued medications (33.9 and 35.4% respectively) whereas more than half of participants initiating risperidone LAI and olanzapine LAI discontinued during the 12 months of follow-up (51.4 and 62.5% respectively). In multivariate analysis being prescribed olanzapine LAI and poor medication adherence at baseline were signifcantly associated with higher discontinuation risk.HumanAntipsychotic Agentsmedicine.drugPsychopathologyAdultmedicine.medical_specialtyDiscontinuationFollow-Up StudieMedication Adherence03 medical and health sciencesmedicineHumansPaliperidoneAdverse effectSettore MED/25 - Psichiatriadiscontinuation ratesPsychiatric Status Rating Scalesrespectively). In multivariate analysisbusiness.industryLong-Acting Antipsychoticlong-acting injectable antipsychoticsSurvival AnalysisConfidence intervalparticipant refusal to continue LAIs and LAIs no longer being required were the most frequently reported reasons for discontinuation. Paliperidone LAI and aripiprazole LAI were the least discontinued medications (33.9 and 35.4%030227 psychiatryDiscontinuationProspective StudieAntipsychotic Agentoccurring in almost 40% of the entire sampleDelayed-Action PreparationsNeurology (clinical)business030217 neurology & neurosurgerybeing prescribed olanzapine LAI and poor medication adherence at baseline were signifcantly associated with higher discontinuation riskFollow-Up Studies
researchProduct

Indacaterol vs tiotropium in COPD patients classified as GOLD A and B

2015

SummaryIntroductionAccording to current GOLD strategy, patients with COPD classified as groups A and B may be treated with inhaled bronchodilators, either long-acting β2-agonist (LABA) or long-acting muscarinic antagonist (LAMA). However, there is little guidance on which class of agent is preferred and a lack of prospective data to differentiate the two.MethodsIn this study, we performed post-hoc analyses of pooled data from two prospective, controlled clinical trials comparing the LABA indacaterol and LAMA tiotropium in 1422 patients with moderate airflow limitation and no history of exacerbations in the previous year. This population fits the definitions of GOLD A and B groups and could …

MalePulmonary and Respiratory MedicineEfficacyPopulationINDEXESQuinolonesOBSTRUCTIVE PULMONARY-DISEASEPulmonary Disease Chronic ObstructiveHumansMedicineCOPDCOHORTProspective StudiesGOLDTiotropium BromideeducationDYSPNEAIndacateroleducation.field_of_studyCOPDDose-Response Relationship Drugbiologybusiness.industryTiotropiumONCE-DAILY INDACATEROLMuscarinic antagonistForced Expiratory Flow RatesBaseline Dyspnea IndexMiddle AgedLamabiology.organism_classificationmedicine.diseaseBronchodilator Agentsrespiratory tract diseasesClinical trialTreatment OutcomeAnesthesiaIndansCohortIndacaterolFemalebusinessCLINICAL METHODSFollow-Up Studiesmedicine.drugRespiratory Medicine
researchProduct

The ‘real-life’ COPD patient in Germany: The DACCORD study

2016

Abstract Introduction DACCORD is an ongoing, longitudinal, non-interventional study within the German COPD National Prospective Registry. This manuscript describes the baseline characteristics of the first 5924 participants, recruited between November 2012 and November 2013. Methods The main inclusion criteria are a physician diagnosis of COPD, age ≥40 years, and initiating or changing COPD maintenance medication. Data collected included: Demographic and disease characteristics; prescribed medication; symptoms; COPD Assessment Test (CAT); modified Medical Research Council dyspnoea score (mMRC); exacerbations; comorbidities; and forced expiratory volume in 1 s (FEV 1 ). Results Approximately…

MalePulmonary and Respiratory MedicineRegistryPediatricsmedicine.medical_specialtyPopulationComorbiditySeverity of Illness IndexPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineBaselineForced Expiratory VolumeGermanyCOPDHumansMedicineProspective StudiesRegistries030212 general & internal medicineeducationObservationalAgededucation.field_of_studyCOPDPrimary Health Carebusiness.industryMiddle AgedExertional dyspnoeamedicine.diseaseComorbidityRegimenTreatment Outcome030228 respiratory systemSpirometryBaseline characteristicsFemaleDisease characteristicsObservational studybusinessRespiratory Medicine
researchProduct

Corneal thickness in children with growth hormone deficiency: The effect of GH treatment.

2014

Abstract OBJECTIVE: The eye represents a target site for GH action, although few data are available in patients with GH deficiency (GHD). Our aim was to evaluate central corneal thickness (CCT) and intraocular pressure (IOP) values in GHD children to assess the role played by GHD or GH treatment on these parameters. DESIGN: In 74 prepubertal GHD children (51M, 23F, aged 10.4±2.4years) we measured CCT and IOP before and after 12months of treatment. A baseline evaluation was also made in 50 healthy children matched for age, gender and body mass index. The study outcome considered CCT and IOP during treatment and their correlations with biochemical and auxological data. RESULTS: No difference …

Malegrowth hormone deficiencymedicine.medical_specialtyIntraocular pressurePediatricsgenetic structuresEndocrinology Diabetes and MetabolismGrowth hormone deficiencySettore MED/13 - EndocrinologiaCorneaEndocrinologyGH treatmentInternal medicineHumansMedicineIn patientCorneal thickneChildDwarfism PituitaryIntraocular PressureBaseline valuesHuman Growth Hormonegrowth hormone deficiency; Corneal thickness; GH treatmentbusiness.industryOrgan Sizemedicine.diseaseeye diseasesEndocrinologyTarget siteGh treatmentFemalesense organsbusinessBody mass indexGH Deficiency
researchProduct

Associations of IGF-1 and Adrenal Androgens with Cognition in Childhood

2019

<b><i>Background:</i></b> Little is known about the association between adrenarche and cognition in general populations of children. We therefore studied the associations of dehydroepiandrosterone sulfate (DHEAS), androstenedione (A4), testosterone, insulin-like growth factor-1 (IGF-1), and adrenarche with cognition among prepubertal children. <b><i>Methods:</i></b> These cross-sectional analyses are based on baseline data of the Physical Activity and Nutrition in Children Study. A total of 387 children (183 girls, 204 boys) were included in the analyses. Raven’s Coloured Progressive Matrices (CPM) score was used to assess nonverbal reasoning.…

Malemedicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolism03 medical and health scienceschemistry.chemical_compoundCognition0302 clinical medicineEndocrinologyDehydroepiandrosterone sulfateRaven's Progressive MatricesParental educationInternal medicineHumansMedicineTestosteroneAndrostenedioneInsulin-Like Growth Factor IChildTestosterone030219 obstetrics & reproductive medicinebusiness.industryAdrenarcheAge FactorsAndrostenedioneCognitionDehydroepiandrosteroneBaseline dataEndocrinologychemistryPediatrics Perinatology and Child HealthFemalebusinessHormone Research in Paediatrics
researchProduct

Model‐based meta‐analysis of the time to first acute urinary retention or benign prostatic hyperplasia‐related surgery in patients with moderate or s…

2021

Aims Combination therapy of 5α‐reductase inhibitor and α‐blocker is a guideline‐endorsed therapeutic approach for patients with moderate‐to‐severe lower urinary tract symptoms or benign prostatic hyperplasia (LUTS/BPH) who are at risk of disease progression. We aimed to disentangle the contribution of clinical and demographic baseline characteristics affecting the risk of acute urinary retention or BPH‐related surgery (AUR/S) from the effect of treatment with drugs showing symptomatic and disease‐modifying properties. Methods A time‐to‐event model was developed using pooled data from patients (n = 10 238) enrolled into six clinical studies receiving placebo, tamsulosin, dutasteride or tamsu…

Malemedicine.medical_specialtydisease‐modifying propertiesCombination therapyProstatic HyperplasiaPlacebo030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicinebaseline risk factorsLower urinary tract symptomsTamsulosinHumansMedicinePharmacology (medical)lower urinary tract symptoms030212 general & internal medicineacute urinary retentionPharmacologybenign prostatic hyperplasiadutasterideSulfonamidesbusiness.industryUrinary retentionHazard ratioOriginal ArticlesUrinary Retentionmedicine.diseaseDutasterideSurgeryTreatment OutcomechemistryAzasteroidstamsulosinOriginal ArticleDrug Therapy CombinationInternational Prostate Symptom Scoremedicine.symptombusinesstime‐to‐event modellingmedicine.drugBritish Journal of Clinical Pharmacology
researchProduct

Hilliness and the Development of Walking Difficulties Among Community-Dwelling Older People

2018

Objective: The objective of this study is to study the associations of objectively defined hilliness with the prevalence and incidence of walking difficulties among community-dwelling older adults, and to explore whether behavioral, health, or socioeconomic factors would fully or partially explain these associations. Method: Baseline interviews ( n = 848, 75-90 years) on difficulties in walking 500 m, frequency of moving through the neighborhood, and perceived hilliness as a barrier to outdoor mobility were conducted. Two-year follow-up interviews ( n = 551) on difficulties in walking 500 m were conducted among participants without baseline walking difficulties. Hilliness objectively defin…

MalevanhuksetasuinympäristömäetWalkingslopesLogistic regression03 medical and health sciencesmobility limitation0302 clinical medicineResidence CharacteristicsRisk FactorsPrevalenceliikuntakykyHumansMedicine030212 general & internal medicineRisk factorBaseline (configuration management)liikuntaesteisetSocioeconomic statusFinlandAgedneighborhoodAged 80 and overCommunity and Home Care030505 public healthpinnanmuodotbusiness.industryIncidence (epidemiology)agingta3141Odds ratioGISConfidence intervalLogistic ModelsMobility LimitationslopeFemaleGeriatrics and Gerontology0305 other medical sciencebusinesshuman activitiesGerontologyneighbourhoodikääntyneetDemographyJournal of Aging and Health
researchProduct